Actelion Pharmaceuticals Ltd

act-213105 - iloprost

 

Study ID Status Type Title
AC-063A301 Completed Protocol Summary A Multicenter, Double-blind, Randomized, Placebo-controlled, Crossover Study to Assess the Effects of a Single Dose of Iloprost Power 15 on Exercise Capacity in Patients with Symptomatic Pulmonary Arterial Hypertension
AC-063A302 Completed Protocol Summary A Multicenter, Double-blind, Randomized Study comparing the Safety and Tolerability of Iloprost inhalation solution delivered by I-neb utilizing Power disc-15 and Power disc-6 in Patients with Symptomatic Pulmonary Arterial Hypertension
AC-063A402 Terminated Protocol Summary A Phase IIIb, multicenter, open-label study of patients with pulmonary arterial hypertension treated with iloprost (inhalation) evaluating safety and inhalation times when converting from power disc-6 (PD-6) to power disc-15 (PD-15) with the I-neb® AAD®
AC-063A501 Completed Protocol Summary Registry to Prospectively Evaluate Use of Ventavis® in Patients with Pulmonary Arterial Hypertension
AC-063B201 Terminated Protocol Summary A Phase 2, multi-center, double-blind, randomized, placebo-controlled study to evaluate the effects of inhaled iloprost on endurance time during cardiopulmonary exercise testing in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease
C200-003 Completed Protocol Summary A Randomized, Double-blind, Placebo-Controlled Phase II Study to Evaluate the Safety and Pilot Efficacy of Iloprost Inhalation Solution in Adults with Abnormal Pulmonary Arterial Pressure and Exercise Limitation Associated with Idiopathic Pulmonary Fibrosis (IPF)
C200-006 Terminated Protocol Summary A Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of the Addition of Inhaled Iloprost in Patients with Pulmonary Arterial Hypertension Receiving Oral Sildenafil
C200-007 Stopped Protocol Summary Safety and Efficacy of Inhaled Iloprost in Pediatric Patients with Pulmonary Arterial Hypertension
C200-008 Terminated Protocol Summary A Comparison of Safety and Inhalation Times of Ventavis (iloprost) Inhalation Solution delivered by I-Neb Utilizing Power Disc-6 and Power Disc-15 "Power 15 Study"